Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic Drug-Drug Interaction Between HUC2A-752-A and HUC2A-752-B in Healthy Adults
Sponsor: Huons Co., Ltd.
Summary
This study evaluates the pharmacokinetic drug-drug interactions of repeated co-administration of HUC2A-752-A and HUC2A-752-B compared to monotherapy of each agent in healthy adults
Official title: An Open-Label, Multiple-oral Dosing, Fixed-Sequence Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic Drug-Drug Interaction Between HUC2A-752-A and HUC2A-752-B in Healthy Adults
Key Details
Gender
All
Age Range
19 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-10
Completion Date
2027-02
Last Updated
2026-08-25
Healthy Volunteers
Yes
Conditions
Interventions
Losartan (COZZAR®)
HUC2A-752-A
Pitavastatin plus Ezetemibe
HUC2A-752-B
Locations (1)
Seoul National University Hospital
Seoul, Jongno-gu, South Korea